Jan Matejovic

Title: Jan Matejovic: Innovator in Pathogen Inactivation

Introduction

Jan Matejovic is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pathogen inactivation, holding 2 patents that focus on innovative methods and compounds for treating biological materials.

Latest Patents

His latest patents include the development of frangible compounds for pathogen inactivation. These compounds and methods are designed to inactivate pathogens in biological materials such as red blood cell preparations and plasma. The inventions describe compositions and methods that can be used for materials intended for both in vitro and in vivo applications, including clinical testing and transfusion. The compounds are engineered to specifically bind to and react with nucleic acids, subsequently degrading to form breakdown products. Notably, the degradation reaction is designed to occur at a slower rate than the reaction with nucleic acids, ensuring effective pathogen inactivation.

Career Highlights

Jan Matejovic is associated with Cerus Corporation, a company known for its advancements in blood safety and pathogen inactivation technologies. His work at Cerus Corporation has positioned him as a key player in the field, contributing to innovations that enhance the safety of blood products.

Collaborations

Throughout his career, Jan has collaborated with esteemed colleagues such as David N Cook and John E Merritt. These collaborations have further enriched his research and development efforts in pathogen inactivation.

Conclusion

Jan Matejovic's contributions to the field of pathogen inactivation through his innovative patents and work at Cerus Corporation highlight his role as a significant inventor. His advancements are crucial for improving the safety of biological materials used in medical applications.